Clinical Trials Logo

Clinical Trial Summary

Coronary Computed Tomography Angiography (CCTA) contrast opacification gradients and FFR-CT estimation can aid in the severity estimation of significant atherosclerotic lesions. Currently, FFR-CT algorithms can only be optimized using theoretical models and can only be validated in large multi-center clinical trials. Using patient specific 3D printed coronary phantoms would allow optimization of FFR-CT algorithms with a measured validation technique without the need for large clinical trials. Thus the investigators believe that this study will result in a FFR-CT algorithm/method with a better predictability for arterial lesion severity than those existing on the market today. Flow measurements will be compared with: CT-FFR for both patients and phantoms, angio lab FFR measurements and 30 days follow-up. This pilot clinical study includes ~50 patients over a year and half at GVI.


Clinical Trial Description

Coronary Computed Tomography Angiography (CCTA) contrast opacification gradients and FFR-CT estimation can aid in the severity estimation of significant atherosclerotic lesions. Following this trend, the investigators recently developed a collaboration between Brigham and Women's Hospital (BWH) and Gates Vascular Institute (GVI). The investigators 3D-printed patient specific coronary phantoms at (GVI) and scanned them with a Toshiba Aquilion scanner to test several aspects of the contrast opacification gradients using a method established at BWH. The initial results showed strong correlation between the flow in the phantom and opacification gradients. The investigators believe that this approach could be further developed to test and validate FFR-CT algorithms. Currently, FFR-CT algorithms can only be optimized using theoretical models and can only be validated in large multi-center clinical trials. This phantom approach would allow optimization of FFR-CT algorithms with a measured validation technique without the need for large clinical trials. Thus the investigators believe that this study will result in a FFR-CT algorithm/method with a better predictability for arterial lesion severity than those existing on the market today. The approach is to use the infrastructure at GVI to perform a detailed validation of the FFR-CT method using 3D printed patient specific phantoms. The subject enrollment criteria is: at least one CCTA, at least one lesion with >50% stenosis or 30-50% and an angio based FFR. Each patient will have a 3D phantom printed, containing the culprit lesion and used in a benchtop flow analysis. Flow measurements will be compared with: CT-FFR for both patients and phantoms, angio lab FFR measurements and 30 days follow-up. This pilot clinical study will include ~50 patients over a year and half at GVI. The investigators are confident that this approach performed via 3D-phantom testing will prove the validity of FFR-CT based measurements as well as develop a new standard for validating FFR-CT algorithms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03149042
Study type Observational
Source State University of New York at Buffalo
Contact
Status Completed
Phase
Start date May 28, 2016
Completion date April 21, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03427996 - Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Not yet recruiting NCT04762472 - Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China Phase 4
Not yet recruiting NCT03174418 - Fluid-dynamics in Bifurcation PCI N/A
Not yet recruiting NCT03813017 - Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
Recruiting NCT05600088 - Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina N/A
Completed NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Phase 4
Completed NCT00115583 - The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries N/A
Not yet recruiting NCT05540223 - Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System N/A
Completed NCT02389946 - Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions N/A
Completed NCT01234870 - Comprehensive Evaluation of Ischemic Heart Disease Using MRI Phase 2/Phase 3
Completed NCT03471611 - Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis Phase 1
Completed NCT00353795 - Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI) N/A
Enrolling by invitation NCT04810364 - HIV Infection And Evolvement of Atherosclerotic Plaque
Active, not recruiting NCT04175626 - Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Recruiting NCT00146887 - Comparison of Coronary CT Angiography to Invasive Coronary Angiography N/A
Completed NCT05492084 - Personalized Risk of Rapidly Progressive Atherosclerosis
Recruiting NCT04853511 - Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability
Completed NCT03815032 - Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison N/A
Active, not recruiting NCT03129503 - Optical Coherence Tomography in Acute Coronary Syndrome
Recruiting NCT06393894 - Latvian Early Atherosclerosis Registry